---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-009132"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T06:05:30.309123+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics engages ShareIntel to investigate potential illegal naked short selling

## Summary
- Engaged Shareholder Intelligence Services (ShareIntel) to probe potential illegal naked short selling and trading irregularities.
- Will use ShareIntel's DRIL-Down™ platform to analyze trading data from broker-dealers and clearing firms.
- CEO Thomas Jensen cites investor inquiries and notable stock volatility as drivers for the investigation.
- If violations of SEC Regulation SHO are found, Allarity will consider legal recourse against responsible parties.
- Investigation aims to protect shareholder value as the company advances clinical development of stenoparib.

## SEC filing metadata
- accession: 0001437749-25-009132
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/0001437749-25-009132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/allr20250324_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-009132
- JSON: https://secwatch.observer/filing/0001437749-25-009132.json
- Plain text: https://secwatch.observer/filing/0001437749-25-009132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.